CD47-Fc fusion proteins as putative immunotherapeutic agents for the treatment of immunological and inflammatory diseases

Bibliography

• Shurin MR, Smolkin YS. Immune-mediated diseases: where do we stand? Adv Exp Med Biol 2007;601:3-12
   PubMedGoogle Scholar
• Smolen JS, Aletaha D, Koeller M, et al. New therapies for treatment of rheumatoid arthritis. Lancet 2007;370:1861-74
   PubMed Web of Science ®Google Scholar
• Toussirot E, Wendling D. The use of TNF-alpha blocking agents in rheumatoid arthritis: an update. Expert Opin Pharmacother 2007;8:2089-107
   PubMed Web of Science ®Google Scholar
• Chitale S, Moots R. Abatacept: the first T lymphocyte co-stimulation modulator, for the treatment of rheumatoid arthritis. Expert Opin Biol Ther 2008;8:115-22
   PubMed Web of Science ®Google Scholar
• Tarner IH, Müller-Ladner U, Gay S. Emerging targets of biologic therapies for rheumatoid arthritis. Nat Clin Pract Rheumatol 2007;3:336-45
   PubMedGoogle Scholar
• Tincani A, Andreoli L, Bazzani C, et al. Inflammatory molecules: a target for treatment of systemic autoimmune diseases. Autoimmun Rev 2007;7:1-7
   PubMedGoogle Scholar
• Barclay AN. Membrane proteins with immunoglobulin-like domains: a master superfamily of interaction molecules. Semin Immunol 2003;15:215-23
   PubMed Web of Science ®Google Scholar
• Brown EJ, Frazier WA. Integrin-associated protein (CD47) and its ligands. Trends Cell Biol 2001;11:130-5
   PubMed Web of Science ®Google Scholar
• Oldenborg PA. Role of CD47 in erythroid cells and in autoimmunity. Leuk Lymphoma 2004;45:1319-27
   PubMed Web of Science ®Google Scholar
• Gardia S, Bratton D, Ogden C, Henson P. Recognition ligands on apoptotic cells: a perspective. J Leukoc Biol 2006;79:896-903
   PubMedGoogle Scholar
• Adams JC. Thrombospondin-1. Int J Biochem Cell Biol 1997;29:861-5
   PubMed Web of Science ®Google Scholar
• Bornstein P. Thrombospondins as matricellular modulators of cell function. J Clin Invest 2001;107:929-34
   PubMed Web of Science ®Google Scholar
• Doyen V, Rubi M, Braun D, et al. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med 2003;198:1277-81
   PubMed Web of Science ®Google Scholar
• Barclay AN, Brown MH. The SIRP family of receptors and immune regulation. Nat Rev Immunol 2006;6:457-64
   PubMed Web of Science ®Google Scholar
• Veillette A, Thibaudeau E, Latour S. High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages. J Biol Chem 1998;273:22719-28
   PubMed Web of Science ®Google Scholar
• Brooke G, Holbrook JD, Brown MH, Barclay AN. Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family. J Immunol 2004;173:2562-70
   PubMed Web of Science ®Google Scholar
• Piccio L, Vermi W, Boles KS, et al. Adhesion of human T cells to antigen-presenting cells through SIRPβ2-CD47 interaction costimulates T-cell proliferation. Blood 2005;105:2121-427
   Google Scholar
• Brown E. Integrin-associated protein (CD47): an unusual activator of G protein signaling. J Clin Invest 2001;107:1499-500
   PubMedGoogle Scholar
• Hatherley D, Harlos K, Dunlop DC, et al. The structure of the macrophage signal regulatory protein alpha (SIRP-alpha) inhibitory receptor reveals a binding face reminiscent of that used by T cell receptors. J Biol Chem 2007;282:14567-75
   PubMed Web of Science ®Google Scholar
• Liu Y, Tong Q, Zhou Y, et al. Functional elements on SIRP-alpha IgV domain mediate cell surface binding to CD47. J Mol Biol 2007;365:680-93
   PubMedGoogle Scholar
• Lee WY, Weber DA, Laur O, et al. Novel structural determinants on SIRP alpha that mediate binding to CD47. J Immunol 2007;179:7741-50
   PubMedGoogle Scholar
• Latour S, Tanaka H, Demeure C, et al. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. J Immunol 2001;167:2547-54
   PubMed Web of Science ®Google Scholar
• Isenberg JS, Frazier WA, Roberts DD. Thrombospondins: from structure to therapeutics. Thrombospondin-1: a physiological regulator of nitric oxide signaling. Cell Mol Life Sci 2008;65:728-42
   PubMed Web of Science ®Google Scholar
• Isenberg JS, Pappan LK, Romeo MJ, et al. Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts. Ann Surg 2008;247:180-90
   PubMed Web of Science ®Google Scholar
• Grimbert P, Bouguermouh S, Baba N, et al. Thrombospondin/CD47 interaction: a pathway to generate regulatory T cells from human CD4+CD25- T cells in response to inflammation. J Immunol 2006;177:3534-41
   PubMed Web of Science ®Google Scholar
• Armant M, Avice MN, Hermann P, et al. CD47 ligation selectively downregulates human interleukin 12 production. J Exp Med 1999;190:1175-82
   PubMed Web of Science ®Google Scholar
• Lamy L, Foussat A, Brown EJ, et al. Interactions between CD47 and thrombospondin reduce inflammation. J Immunol 2007;178:5930-9
   PubMed Web of Science ®Google Scholar
• Okazawa H, Motegi S, Ohyama N, et al. Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system. J Immunol 2005;174:2004-11
   PubMed Web of Science ®Google Scholar
• Liu Y, O'Connor MB, Mandell KJ, et al. Peptide-mediated inhibition of neutrophil transmigration by blocking CD47 interactions with signal regulatory protein alpha. J Immunol 2004;172:2578-85
   PubMed Web of Science ®Google Scholar
• Alblas J, Honing H, De Lavalette CR, et al. Signal regulatory protein alpha ligation induces macrophage nitric oxide production through JAK/STAT- and phosphatidylinositol 3-kinase/Rac1/NAPDH oxidase/H2O2-dependent pathways. Mol Cell Biol 2005;25:7181-92
   PubMedGoogle Scholar
• Braun D, Galibert L, Nakajima T, et al. Semimature stage: a checkpoint in a dendritic cell maturation program that allows for functional reversion after signal-regulatory protein-alpha ligation and maturation signals. J Immunol 2006;177:8550-9
   PubMedGoogle Scholar
• Fukunaga A, Nagai H, Noguchi T, et al. Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the migration of Langerhans cells from the epidermis to draining lymph nodes. J Immunol 2004;172:4091-9
   PubMedGoogle Scholar
• Fukunaga A, Nagai H, Yu X, et al. Src homology 2 domain-containing protein tyrosine phosphatase substrate 1 regulates the induction of Langerhans cell maturation. Eur J Immunol 2006;36:3216-26
   PubMedGoogle Scholar
• Lindberg FP, Bullard DC, Caver TE, et al. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 1996;274:795-8
   PubMed Web of Science ®Google Scholar
• Verdrengh M, Lindberg FP, Ryden C, Tarkowski A. Integrin-associated protein (IAP)-deficient mice are less susceptible to developing Staphylococcus aureus-induced arthritis. Microbes Infect 1999;1:745-51
   PubMed Web of Science ®Google Scholar
• Hagnerud S, Manna PP, Cella M, et al. Deficit of CD47 results in a defect of marginal zone dendritic cells, blunted immune response to particulate antigen and impairment of skin dendritic cell migration. J Immunol 2006;176:5772-8
   PubMedGoogle Scholar
• Parkinson JE, Sanderson CM, Smith GL. The vaccinia virus A38L gene product is a 33-kDa integral membrane glycoprotein. Virology 1995;214:177-88
   PubMedGoogle Scholar
• Seet BT, Johnston JB, Brunetti CR, et al. Poxviruses and immune evasion. Ann Rev Immunol 2003;21:377-423
   PubMedGoogle Scholar
• Cameron CM, Barrett JW, Mann M, et al. Myxoma virus M128L is expressed as a cell surface CD47-like virulence factor that contributes to the downregulation of macrophage activation in vivo. Virology 2005;337:55-67
   PubMedGoogle Scholar
• Gao AG, Lindberg FP, Finn MB, et al. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem 1996;271:21-4
   PubMed Web of Science ®Google Scholar
• Cooper D, Lindberg FP, Gamble JR, et al. Transendothelial migration of neutrophils involves integrin-associated protein (CD47). Proc Natl Acad Sci USA 1995;92:3978-82
   PubMed Web of Science ®Google Scholar
• Parkos CA, Colgan SP, Liang TW, et al. CD47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia. J Cell Biol 1996;132:437-50
   PubMedGoogle Scholar
• Isenberg JS, Romeo MJ, Abu-Asab M, et al. Increasing survival of ischemic tissue by targeting CD47. Circ Res 2007;100:712-20
   PubMed Web of Science ®Google Scholar
• Blystone SD, Lindberg FP, Laflamme SE, Brown EJ. Integrin beta 3 cytoplasmic tail is necessary and sufficient for regulation of alpha 5 beta 1 phagocytosis by alpha v beta 3 and integrin-associated protein. J Cell Biol 1995;130:745-54
   PubMed Web of Science ®Google Scholar
• Avice MN, Rubio M, Sergerie M, et al. CD47 ligation selectively inhibits the development of human naive T cells into Th1 effectors. J Immunol 2000;165:4624-31
   PubMedGoogle Scholar
• Avice MN, Rubio M, Sergerie M, et al. Role of CD47 in the induction of human naive T cell anergy. J Immunol 2001;167:2459-68
   PubMedGoogle Scholar
• Reinhold MI, Lindberg FP, Kersh GJ, et al. Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway. J Exp Med 1997;185:1-11
   PubMedGoogle Scholar
• Yu X, Fukunaga A, Nagai H, et al. Engagement of CD47 inhibits the contact hypersensitivity response via the suppression of motility and B7 expression by Langerhans cells. J Invest Dermatol 2006;126:797-807
   PubMedGoogle Scholar
• Liu Y, Buhring HJ, Zen H, et al. Signal regulatory protein (SIRP), a cellular ligand for CD47, regulates neutrophil transmigration. J Biol Chem 2002;277:10028-36
   PubMedGoogle Scholar
• Sarfati M. WO9940940; 1999
   Google Scholar
• Med. Res. Council; Barclay N. WO0148020; 2001
   Google Scholar
• Japan Sci. & Tech. Agency. EP1637598; 2006
   Google Scholar
• Emory Univ. US7282556; 2007
   Google Scholar
• Viral Logic Systems Technology. WO2007133811; 2007
   Google Scholar
• Probst P, Skeiky YA, Steeves M, et al. A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells. Eur J Immunol 1997;27:2634-42
   PubMed Web of Science ®Google Scholar
• Boruchov AM, Heller G, Veri MC, et al. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest 2005;115:2914-23
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Fc-receptors as regulators of immunity. Adv Immunol 2007;96:179-204
   PubMed Web of Science ®Google Scholar
• Terato K, Harper DS, Griffiths MM, et al. Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity 1995;22:137
   PubMed Web of Science ®Google Scholar
• Wallace PM, MacMaster JF, Rouleau KA, et al. Regulation of inflammatory responses by oncostatin M. J Immunol 1999;162:5547-55
   PubMedGoogle Scholar
• Nandakumar KS, Holmdahl R. Collagen antibody-induced arthritis. Methods Mol Med 2007;136:215-23
   PubMedGoogle Scholar
• Rebres RA, Vaz LE, Green JM, Brown EJ. Normal ligand binding and signaling by CD47 (integrin-associated protein) requires a long range disulfide bond between the extracellular and membrane-spanning domains. J Biol Chem 2001;276:34607-16
   PubMed Web of Science ®Google Scholar
• Subramanian S, Boder ET, Discher DE. Phylogenetic divergence of CD47 interactions with human signal regulatory protein alpha reveals locus of species specificity. Implications for the binding site. J Biol Chem 2007;282:1805-18
   PubMed Web of Science ®Google Scholar
• Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006;311:17-58
   PubMed Web of Science ®Google Scholar
• Manuel SL, Rahman S, Wigdahl B, et al. Dendritic cells in autoimmune diseases and neuroinflammatory disorders. Front Biosci 2007;12:4315-35
   PubMedGoogle Scholar
• Van Roon JA. Activating and inhibitory Fc gamma receptors in rheumatoid arthritis: from treatment to targeted therapies. Arthritis Res Ther 2007;9:106
   PubMedGoogle Scholar
• Vallejo AN, Yang H, Klimiuk PA, et al. Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction. J Immunol 2003;171:1732-40
   PubMedGoogle Scholar
• Hegen M, Keith JC, Collins M, Nickerson-Nutter CL. Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis 2007 Nov 29; [Epub ahead of print]
   PubMedGoogle Scholar